BELMONITOR COV-2
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79305894
- Registration number
- 6720755
- Mark type
- Design + words
- Filed
- 22 Dec 2020
- Published for opposition
- 22 Feb 2022
- Registered
- 24 May 2022
- Attorney of record
- Brian P. Gregg
Goods and services
- Class 005 — Pharmaceuticals: Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2
- Class 010 — Medical apparatus: Genetic testing apparatus for medical purposes for diagnosing exposure to Sars-Cov-2; chromatogram analyzers for medical use; patient monitoring sensors and alarms; chromatographic instruments for medical use; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; chromatographic apparatus for medical use; physical analyzers for medical use, namely, hematology analyzers for medical diagnostic uses, body composition analyzers for medical purposes, skin moisture analyzers for medical purposes, analyzers for the analysis of body fluids; medical diagnostic saliva pads; immunoadsorption columns for medical diagnostic use; chromatographic columns for medical use; apparatus for blood monitoring for medical use; spittoons for medical purposes; all of the foregoing for use in diagnosing or treating Sars-Cov-2 infections
Owner
- Rainer Böhnke, DE
- Rainer Böhnke, DE
- Rainer Böhnke, DE
- PharmACT Holding AG, CH
- PharmACT Holding AG, CH
- PharmACT Holding AG, CH
Prosecution history
- 07 Nov 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Sept 2022 — GENERIC MADRID TRANSACTION SENT TO IB
- 14 Sept 2022 — GENERIC MADRID TRANSACTION CREATED
- 24 Aug 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Feb 2022 — PUBLISHED FOR OPPOSITION
- 20 Feb 2022 — NOTIFICATION PROCESSED BY IB
- 02 Feb 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Feb 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 02 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jan 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jan 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE